Bloodstream infections in febrile neutropenic patients at a tertiary care center in Lebanonon: a view of the past decade

被引:37
作者
Kanafani, Zeina A.
Dakdouki, Ghenwa K.
El-Chammas, Khalil I.
Eid, Shaker
Araj, George F.
Kanj, Souha S.
机构
[1] Amer Univ Beirut, Ctr Med, Div Infect Dis, Beirut 11032090, Lebanon
[2] Amer Univ Beirut, Ctr Med, Dept Pathol & Lab Med, Beirut, Lebanon
[3] Amer Univ Beirut, Ctr Med, Dept Internal Med, Beirut, Lebanon
[4] Amer Univ Beirut, Ctr Med, Dept Pediat, Beirut, Lebanon
[5] Hammoud Hosp, Sidon, Lebanon
[6] Duke Univ, Med Ctr, Div Infect Dis, Durham, NC USA
关键词
neutropenic fever; bacteremia; gram-negative infection; Lebanon;
D O I
10.1016/j.ijid.2006.12.008
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: Previous studies from Lebanon have shown Gram-negative organisms to be the predominant agents in febrile neutropenic patients. The objective of this study was to evaluate the most current epidemiological trends among patients with neutropenic fever. Methods: This prospective observational cohort study, the largest to date in the country, was conducted at the American University of Beirut Medical Center between January 2001 and December 2003, with the objective of describing the characteristics of patients with neutropenic fever and to assess temporal trends. Results: We included 177 episodes of neutropenic fever. The most common underlying malignancy was lymphoma (42.4%). Gastrointestinal and abdominal infections were predominant (31.6%) and 23.7% of cases represented fever of unknown origin. Gram-negative organisms were responsible for 78.8% (26/33) of bloodstream infections compared to 33.3% (11/33) with Gram-positive organisms. The in-hospital mortality rate in this study (12.1%) was considerably lower than in previous years. Conclusions: Gram-negative organisms are persistently predominant in our center. In a developing country like Lebanon with limited resources, tower mortality rates commensurate with worldwide reports were successfully achieved in this high-risk patient population. Protocols and guidelines should be adapted to the characteristics of individual institutions to ensure delivery of appropriate care to febrile neutropenic patients. (C) 2007 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:450 / 453
页数:4
相关论文
共 22 条
[1]   Aerobic bacterial and fungal infections in peripheral blood stem cell transplants [J].
Aksu, G ;
Ruhi, MZ ;
Akan, H ;
Bengisun, S ;
Üstün, C ;
Arslan, Ö ;
Özenci, H .
BONE MARROW TRANSPLANTATION, 2001, 27 (02) :201-205
[2]   FEBRILE NEUTROPENIA IN CANCER-PATIENTS IN KUWAIT - MICROBIAL SPECTRUM AND OUTCOME [J].
ALBAHAR, S ;
PANDITA, R ;
DHABHAR, BN ;
ALBAHAR, E .
SUPPORTIVE CARE IN CANCER, 1994, 2 (06) :400-402
[3]   SEPTICEMIA IN FEBRILE NEUTROPENIC CHILDREN WITH CANCER IN SAUDI-ARABIA [J].
ALFAWAZ, IM ;
KAMBAL, AM ;
ALRABEEAH, AA ;
ALRASHEED, SA ;
ALEISSA, YA ;
FAMILUSI, JB .
JOURNAL OF HOSPITAL INFECTION, 1991, 18 (04) :307-312
[4]   A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies [J].
Cherif, H ;
Björkholm, M ;
Engervall, P ;
Johansson, P ;
Ljungman, P ;
Hast, R ;
Kalin, M .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2004, 36 (08) :593-600
[5]   Microbiological findings in febrile neutropenia [J].
Gaytán-Martínez, J ;
Mateos-García, E ;
Sánchez-Cortés, E ;
González-Llaven, J ;
Casanova-Cardiel, LJ ;
Fuentes-Allen, JL .
ARCHIVES OF MEDICAL RESEARCH, 2000, 31 (04) :388-392
[6]  
Ghosn M, 1994, J Med Liban, V42, P117
[7]  
Hamzeh F, 2000, J Med Liban, V48, P136
[8]   Incidence of septicaemias and invasive mycoses in children undergoing treatment for solid tumours: a 12-year experience at a single Italian institution [J].
Haupt, R ;
Romanengo, M ;
Fears, T ;
Viscoli, C ;
Castagnola, E .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (18) :2413-2419
[9]   2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer [J].
Hughes, WT ;
Armstrong, D ;
Bodey, GP ;
Bow, EJ ;
Brown, AE ;
Calandra, T ;
Feld, R ;
Pizzo, PA ;
Rolston, KVI ;
Shenep, JL ;
Young, LS .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (06) :730-751
[10]   Spectrum and activity of three contemporary fluoroquinolones tested against Pseudomonas aeruginosa isolates from urinary tract infections in the SENTRY Antimicrobial Surveillance Program (Europe and the Americas; 2000):: More alike than different! [J].
Jones, RN ;
Beach, ML ;
Pfaller, MA .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2001, 41 (03) :161-163